Press Release

VIS Matures Rating of Short Term Sukuk-3 (STS-3) of Citi Pharma Limited

Karachi, June 30, 2026: VIS Credit Rating Company Limited (VIS) has matured the rating assigned of Short Term Sukuk-3 (STS-3) issue of PKR 2,000 million of Citi Pharma Limited (‘CPHL’ or the ‘Company’). The instrument was issued in December 31, 2025 and redeemed on June 30, 2026. The previous rating action was announced on January 21, 2026.

For further information on this ratings announcement, please contact at 021-35311861-64 or email at info@vis.com.pk.

Applicable Rating Criteria: Corporates:
Policy for Suspension and Withdrawals of Ratings
https://docs.vis.com.pk/docs/policy_withdrawal.pdf

Information herein was obtained from sources believed to be accurate and reliable; however, VIS Credit Rating Company Limited (VIS) does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. VIS, the analysts involved in the rating process and members of its rating committee do not have any conflict of interest relating to the rating(s)/ranking(s) mentioned in this report. VIS is paid a fee for most rating assignments. This rating/ranking is an opinion and is not a recommendation to buy or sell any securities. Copyright June 30, 2026 VIS Credit Rating Company Limited. All rights reserved. Contents may be used by news media with credit to VIS.